Our goal has been reset and is now $2,500,000, these funds will enable clinical trial evaluation using a larger sample of malaria naive human volunteers to show that the vaccine actually works; that is, that PlasProtecT® can protect people from malaria infection (2017-18). We are well on our way in fact we have exceeded our original goal with $1,330,000 raised!

We appreciate all donations, thank you to those who have generously donated.